Report overview and key themes This report summarizes the input provided by patients and patient representatives at the meeting or through the webcast. It also includes a summary of comments submitted to the public docket. To the extent possible, the terms used in this report to describe specific HD symptoms, impacts, and treatment experiences reflect the words used by in-person participants, web participants, or docket commenters. The report is not meant to be representative in any way of the views and experiences of any specific group of individuals or entities. There may be symptoms, impacts, treatments, or other aspects of the disease that are not included in the report.
The input from the meeting and docket comments underscore the diversity in patients’ experiences with HD, the debilitating side effects of treatment, and the physical, emotional, and social impacts the disease can exert on patients’ lives. Several key themes emerged from this meeting:
• HD is a devastating and debilitating disease that has a tremendous impact on patients and their families. Participants strongly emphasized that psychiatric and behavioral issues were the most significant symptoms of HD. A wide range of other symptoms were also described, including cognitive impairments, motor issues, depression, anxiety, and speech impairments. Many participants commented on the destructive impact of HD on multiple generations of their families.
• Participants said that current treatments do not adequately manage their most disabling symptoms. Participants commented that while some medications were effective in managing some symptoms, most treatment regimens were altered to add more medication or increase dosing as HD symptoms progressed. Nearly all participants said that they value the benefits they see in non-drug therapies, such as exercise, dietary modifications, lifestyle changes (to minimize stress), meditation, and prayer.
• HD impacts all aspects of patients’ lives. Participants described severe limitations on physical activity, loss of independence and increased reliance on others for care, the devastating impact on relationships, and a constant fear of passing the disease onto their children. Participants shared that the cognitive impairments of HD often left them or their loved ones socially isolated, which worsened their depression and anxiety.
• Participants stressed the need for medications that are effective in delaying the onset of symptoms or slowing the progression of symptoms. Other participants emphasized the need for improved research on a cure for HD (including gene silencing therapies and stem cell therapies), faster clinical trials and drug development, and expedited drug reviews.
U.S. Food and Drug Administration (FDA)
Disease Category: Neurology
Disease Name: Huntington's disease
Age Range: Unknown
Sex:
Nature of Intervention:
- Patient perspectives